These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8455193)

  • 1. Discovering switch pharmaceuticals from multistationary biochemical networks.
    Morrison PF; Dedrick RL
    J Natl Cancer Inst; 1993 Apr; 85(7):518-9. PubMed ID: 8455193
    [No Abstract]   [Full Text] [Related]  

  • 2. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
    Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
    Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Just getting into cells is not enough.
    Park K
    J Control Release; 2013 Jul; 169(1-2):162. PubMed ID: 23763953
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acquisition of resistance to anticancer agents by overproduction of target enzymes].
    Inaba M
    Nihon Rinsho; 1997 May; 55(5):1030-7. PubMed ID: 9155148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
    Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
    Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic simulation of anticancer drug effects on metabolic pathway fluxes: two case studies.
    Jackson RC
    Bull Math Biol; 1986; 48(3-4):337-51. PubMed ID: 3828562
    [No Abstract]   [Full Text] [Related]  

  • 7. The kinetic properties of switch antimetabolites.
    Jackson RC
    J Natl Cancer Inst; 1993 Apr; 85(7):539-45. PubMed ID: 8455200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribonucleotide reductases: radical enzymes with suicidal tendencies.
    Stubbe J; Booker S; Broderick J; Mao SS; Ator M; Harris G; Ashley G; Linn AE; Yu GX
    Nucleic Acids Symp Ser; 1993; (29):107. PubMed ID: 8247726
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
    Nakano K; Todo T; Zhao G; Yamaguchi K; Kuroki S; Cohen JB; Glorioso JC; Tanaka M
    J Gene Med; 2005 May; 7(5):638-48. PubMed ID: 15754306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductases and their occurrence in microorganisms: a link to the RNA/DNA transition.
    Harder J
    FEMS Microbiol Rev; 1993 Nov; 12(4):273-92. PubMed ID: 8268003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic profiling for cancer surfaces slowly in the clinic.
    Nelson NJ
    J Natl Cancer Inst; 1999 Dec; 91(23):1990-2. PubMed ID: 10580015
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantum chemical studies of intermediates and reaction pathways in selected enzymes and catalytic synthetic systems.
    Noodleman L; Lovell T; Han WG; Li J; Himo F
    Chem Rev; 2004 Feb; 104(2):459-508. PubMed ID: 14871132
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of thiols by ribonucleotide reductase.
    Holmgren A; Sengupta R
    Free Radic Biol Med; 2010 Dec; 49(11):1617-28. PubMed ID: 20851762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.
    Chen MC; Zhou B; Zhang K; Yuan YC; Un F; Hu S; Chou CM; Chen CH; Wu J; Wang Y; Liu X; Smith DL; Li H; Liu Z; Warden CD; Su L; Malkas LH; Chung YM; Hu MC; Yen Y
    Mol Pharmacol; 2015 Jun; 87(6):996-1005. PubMed ID: 25814515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine.
    Xie KC; Plunkett W
    Cancer Res; 1996 Jul; 56(13):3030-7. PubMed ID: 8674058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical biochemical pharmacology of anticancer antimetabolites: introductory remarks.
    Mihich E
    Bull Cancer; 1979; 66(1):37-8. PubMed ID: 420945
    [No Abstract]   [Full Text] [Related]  

  • 17. Ribonucleotide reductases.
    Jordan A; Reichard P
    Annu Rev Biochem; 1998; 67():71-98. PubMed ID: 9759483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer.
    Matsusaka S; Yamasaki H; Fukushima M; Wakabayashi I
    Chemotherapy; 2007; 53(1):36-41. PubMed ID: 17192711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductases: the evolution of allosteric regulation.
    Reichard P
    Arch Biochem Biophys; 2002 Jan; 397(2):149-55. PubMed ID: 11795865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The biochemistry of the cancer cell. Purine and pyrimidine metabolism].
    Pillwein K; Jayaram HN; Wever G
    Padiatr Padol; 1986; 21(4):323-34. PubMed ID: 3562043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.